A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer. Read more ...

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

Genetic testing and at-home screenings for colon, prostate and cervical cancer give workers and their families access to ...

"The scale and scope of data to be presented at the ASCO GU meeting underscore the impact our whole-transcriptome-based Decipher tests are having in treating patients with urologic cancers, and how ...

Dante’s oncologist, Dr. Bernie Eigl, deputy head, department of clinical research at BC Cancer, referred him to a BC Cancer ...

He clicked open a dashboard created by Nucleus Genomics, a Founders Fund-backed startup that ... he concluded that he had a predisposition for schizophrenia, a sky-high IQ, and prostate cancer.

A new study suggests that genetically predicted rheumatoid arthritis (RA) may increase the risk of developing prostate cancer ...

A patient found to carry a BRCA1 pathogenic variant is not referred to a certified genetic counselor in her health system.

This collaboration will streamline the ordering and delivery of molecular tests, enabling healthcare providers to electronically order and track Prolaris and MyRisk tests, with results delivered ...